Cargando…

Suicidality in Treatment-Resistant Depression Patients

INTRODUCTION: Depression and treatment-resistant depression (RD) are associated with suicidal behavior (SB) at a higher rate. OBJECTIVES: 1) determination prevalence of RD in district outpatient psychiatric сlinics (i.e., dispensaries) and the socio-demographic characteristics of RD patients with SB...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyubov, E. B., Semenova, N. D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434094/
http://dx.doi.org/10.1192/j.eurpsy.2023.704
Descripción
Sumario:INTRODUCTION: Depression and treatment-resistant depression (RD) are associated with suicidal behavior (SB) at a higher rate. OBJECTIVES: 1) determination prevalence of RD in district outpatient psychiatric сlinics (i.e., dispensaries) and the socio-demographic characteristics of RD patients with SB. METHODS: In this multicenter (3 sites), retrospective, observational epidemiological study, patients (n=148) with diagnoses F 30-39 (ICD-10) were recruited in 2020. Patients (n=22) were assessed for RD, defined as failure to respond to ≥ two antidepressant medications of adequate dose and duration for at least three months. RESULTS: The prevalence of depression is ≤ 2% of the outpatient population. RD prevalence ˜15%. SB (i.e., suicidal attempts) was noted in every fifth (n=5) for the index year. SB patients differed in the following typical features: a woman (82%) mean age, 46.8 years with long-term (≥ 10 years) depression and annual hospitalizations for three years (61.4 days per patient), and with suicidal attempts (repeated within the last two years) through (80%) self-poisoning with psychotropic drugs. Nobоdy worked, and everyone was divorced. CONCLUSIONS: On the background of ubiquitous underdiagnosis of depressive disorders in routine practice, RD patients with SP represent a high-resource users group with combined clinical and social problems requiring pharmacotherapy and target psychosocial rehabilitation. DISCLOSURE OF INTEREST: None Declared